SecBot SecBot
SECBOTREPLAY Home › Report › HCA

HCA · HCA Healthcare has filed its definitive proxy statement (DEFA14A) for…

HCA Healthcare, Inc. · DEFA14A filed Mar 13, 2026 at 16:12 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Mar 13, 2026 at 16:12 ET

HCA Healthcare has filed its definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for April 23, 2026. The filing outlines the board's recommendations for shareholder votes on the election of nine director nominees, the ratification of Ernst & Young as the independent auditor, an advisory vote on executive compensation, and opposition to two shareholder proposals regarding a healthcare consequences report and shareholder rights to act by written consent.

  • The filing is a definitive proxy statement (DEFA14A) for HCA Healthcare's 2026 Annual Meeting.
  • The meeting is scheduled for April 23, 2026, and voting must be completed by April 22, 2026.
  • The board recommends voting 'For' the election of all nine director nominees: Thomas F. Frist III, Samuel N. Hazen, John W. Chidsey, III, Nancy-Ann DeParle, William R. Frist, Hugh F. Johnston, Michael W. Michelson, Wayne J. Riley, M.D., and Andrea B. Smith.
  • The board recommends voting 'For' the ratification of Ernst & Young LLP as the independent auditor.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access